Szot Matthew K is Chief Financial Officer of Cadrenal Therapeutics, Inc. Common Stock.
Person profile
Roles
Address
Hanford, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
SenesTech, Inc.
28 Aug 24
4
Cadrenal Therapeutics, Inc.
19 Jan 24
4
SenesTech, Inc.
29 Jun 23
4
INVO Bioscience, Inc.
22 May 23
4
Cadrenal Therapeutics, Inc.
24 Jan 23
3
Cadrenal Therapeutics, Inc.
19 Jan 23
4
SenesTech, Inc.
6 Jul 22
4
INVO Bioscience, Inc.
3 Jun 22
4
INVO Bioscience, Inc.
18 Jan 22
4
S&W Seed Co
7 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Aug 24 | SNES SenesTech | Stock Option Common Stock | Grant | Acquire A | No | No | 2.81 | 12,090 | 33.97 k | 12,090 |
18 Jan 24 | CVKD Cadrenal Therapeutics, Inc. Common Stock | Stock Options Common Stock | Grant | Acquire A | No | No | 0.94 | 250,000 | 235.00 k | 250,000 |
26 Jun 23 | SNES SenesTech | Stock Option Common Stock | Grant | Acquire A | No | No | 1.25 | 39,402 | 49.25 k | 39,402 |
18 May 23 | INVO INVO Bioscience | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 85,000 | 31.28 k | 85,000 |